Influence of Rivaroxaban for Intermittent Claudication and Exercise Tolerance in Patients With Symptomatic PAD
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Aspirin
Related studies linked through entity extraction aliases.
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
- Status
- RECRUITING
- Phase
- PHASE2
Personalizing Aspirin Therapy in Peripheral Arterial Disease Patients
- Status
- UNKNOWN
- Phase
- NA
Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention
- Status
- RECRUITING
- Phase
- PHASE4
A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis
- Status
- RECRUITING
- Phase
- PHASE3
Double Randomized and Placebo Controlled Trail of Sanchitongshu Combined Antiplatelet Drug to Prevent Ischemic Stroke
- Status
- UNKNOWN
- Phase
- NA
Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST)
- Status
- UNKNOWN
- Phase
- PHASE4
Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease
- Status
- COMPLETED
- Phase
- PHASE3
Asprin Dosing Estimator in Healthy Adults
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
The Safety and Efficacy of RIC on Adult Moyamoya Disease
- Status
- COMPLETED
- Phase
- NA
Pharmacokinetic and Pharmacodynamic Assessment of a Novel, Pharmaceutical Lipid-Aspirin Complex
- Status
- COMPLETED
- Phase
- PHASE1
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
- Status
- COMPLETED
- Phase
- PHASE4
MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention
- Status
- RECRUITING
- Phase
- PHASE3
Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBM
- Status
- COMPLETED
- Phase
- PHASE2
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- Status
- RECRUITING
- Phase
- PHASE3
INdobufen Versus aSpirin in acUte Ischemic stRokE,INSURE
- Status
- COMPLETED
- Phase
- PHASE4
The Impact of Aspirin Dose Modification on the Innate Immune Response - Will Lower Dose Aspirin Therapy Reduce the Response to Endotoxin
- Status
- COMPLETED
- Phase
- PHASE4
Effect of Platelet Inhibition and / or Lipid Lowering in Non-ACS-patients With Positive Troponin
- Status
- TERMINATED
- Phase
- PHASE3